Currently Viewing:
Newsroom
Currently Reading
Men With Advanced Cancers Respond Better Than Women to Immune Checkpoint Inhibitors
July 20, 2018 – Samantha DiGrande
Brain Iron Levels Associated With Disability, Disease Progression in MS
July 20, 2018 – Samantha DiGrande
Solution Will Keep Most Clinical Guidelines Online, This Time for a Fee
July 20, 2018 – Allison Inserro
5 Vulnerable Populations in Healthcare
July 20, 2018 – Laura Joszt
Who Uses e-Cigarettes More: Current Smokers or Former Smokers?
July 20, 2018 – Allison Inserro
AJMC® in the Press, July 20, 2018
July 20, 2018 – AJMC Staff
Rate of Osteoporosis Drug Treatment to Prevent Recurrent Fractures Dropping
July 20, 2018 – Allison Inserro
FDA Expands Use of Ribociclib in Breast Cancer
July 20, 2018 – Laura Joszt
Systematic Review Suggests Protein-Rich Diet Is Beneficial for Bone Health
July 20, 2018 – Alison Rodriguez

LLS Survey Shows Lack of Blood Cancer Awareness in the United States

Alison Rodriguez
A recent survey by The Leukemia & Lymphoma Society found that the majority of adults are surprised by the prevalence of blood cancers-specifically the prevalence of acute lymphocytic leukemia among children and young adults.
A recent survey by The Leukemia & Lymphoma Society (LLS) found that the majority of adults are surprised by the prevalence of blood cancers—specifically the prevalence of acute lymphocytic leukemia (ALL) among children and young adults.

LLS, the world’s largest voluntary non-profit, investigated the awareness of Americans on the impact of blood cancers, including leukemia, lymphoma, and myeloma. The survey revealed that more than 4 in 5 adults (82%) are surprised that blood cancer is the third leading cancer in terms of mortality.

“As there are no means of preventing or screening for most blood cancers, we are focused on finding cures and ensuring that patients have access to lifesaving treatments,” said Louis J. DeGennaro, PhD, president and CEO of LLS. “During Blood Cancer Awareness Month, we drive home the urgent unmet need presented by the blood cancers.”

Additionally, the survey demonstrated that almost 4 in 5 adults (78%) are surprised that ALL is the most common cancer among those under 20 years old. While leukemia was revealed to be the most well-known among adults (72%), only 24% associated lymphoma with being a blood cancer and only 12% related myeloma as a blood cacner.

“With LLS’s support we’ve seen remarkable progress in just the past few years, and 2017 is shaping up to be a banner year for new blood cancer therapies” because of FDA approvals, explained DeGennaro.

Furthermore, 86% of people that participated in the survey were surprised that there are no ways of preventing or screenings for most blood cancers and 82% were surprised that more than one-third of blood cancer patients do not survive more than 5 years following diagnosis. The researchers emphasized the importance to change this as more than 1.3 million Americans are living with or in remission from blood cancer, while a new patient is diagnosed every 3 minutes in the United States, and someone dies every 9 minutes, according to the report.

“Earlier this year, after 4 decades with no change in the standard of care for acute myeloid leukemia (AML), one of the most deadly forms of blood cancer, 3 new therapies were approved by the FDA. In the past 4 years, new therapies were approved for chronic lymphocytic leukemia (CLL) and myeloma,” concluded DeGennaro. “We’re closer than ever to cures.”

The LLS hoped to create more awareness of blood cancers during its Blood Cancer Awareness Month campaign was intended to encourage people around in the world to fight blood cancer in September.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!